CRGE - Clenergen Corp. Stock Price, Fair Value and News

0.01USD0.00 (0.00%)Market Closed

Market Summary

USD0.010.00

Market Closed

0.00%

CRGE Stock Price

View Fullscreen

CRGE RSI Chart

CRGE Valuation

Market Cap

2.2M

Price/Earnings (Trailing)

-0.06

Price/Sales (Trailing)

EV/EBITDA

-4.98

Price/Free Cashflow

3.47

CRGE Price/Sales (Trailing)

CRGE Profitability

EBT Margin

-1.21%

Return on Equity

-153.26%

Return on Assets

-19.7%

Free Cashflow Yield

28.85%

CRGE Fundamentals

CRGE Revenue

Revenue (TTM)

641.4M

Rev. Growth (Yr)

-28.83%

Rev. Growth (Qtr)

-10.37%

CRGE Earnings

Earnings (TTM)

-37.0M

Earnings Growth (Yr)

-148.25%

Earnings Growth (Qtr)

21.42%

Breaking Down CRGE Revenue

Last 90 days

-93.7%

Trailing 12 Months

-99.1%

How does CRGE drawdown profile look like?

CRGE Financial Health

Current Ratio

0.94

CRGE Investor Care

Shares Dilution (1Y)

4.06%

Diluted EPS (TTM)

-0.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	728.4M	694.9M	641.4M	0
2022	528.9M	580.3M	649.2M	697.8M
2021	182.8M	280.9M	378.9M	477.0M
2020	0	0	0	84.7M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Clenergen Corp.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 14, 2023	jacobs gary n	bought	1,860	0.62	3,000	-
Sep 14, 2023	biehl james	bought	6,800	0.68	10,000	clo, cco, secretary
Sep 11, 2023	jacobs gary n	bought	2,800	0.56	5,000	-
Sep 08, 2023	wojtowicz michael	bought	14,100	0.47	30,000	ceo, pres. b w electrical serv
Sep 08, 2023	deutsch justin	bought	48,484	0.46	105,400	-
Sep 08, 2023	biehl james	bought	4,700	0.47	10,000	clo, cco, secretary
Sep 08, 2023	scala philip	bought	21,120	0.48	44,000	-
Sep 08, 2023	schweller leah	bought	14,400	0.48	30,000	cfo
Jun 02, 2023	jacobs gary n	bought	1,960	0.98	2,000	-
May 26, 2023	jacobs gary n	bought	1,010	1.01	1,000	-

Which funds bought or sold CRGE recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	sold off	-100	-2,000	-	-%
Apr 23, 2024	Charter Oak Capital Management, LLC	sold off	-100	-4,564	-	-%
Apr 22, 2024	WEYBOSSET RESEARCH & MANAGEMENT LLC	unchanged	-	204,032	224,000	0.08%
Apr 19, 2024	Cutler Group LLC / CA	sold off	-100	-	-	-%
Apr 18, 2024	WOLFF WIESE MAGANA LLC	sold off	-100	-15.00	-	-%
Apr 16, 2024	Maltin Wealth Management, Inc.	sold off	-100	-10,522	-	-%
Apr 05, 2024	CWM, LLC	unchanged	-	-	-	-%
Mar 11, 2024	VANGUARD GROUP INC	reduced	-0.22	-2,001,910	594,548	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	83.86	-140,887	102,830	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	added	0.6	-25,709	7,716	-%

Are Funds Buying or Selling CRGE?

Are funds buying CRGE calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CRGE

No. of Funds

Unveiling Clenergen Corp.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 16, 2024	orr ken	6.5%	12,394,593	SC 13D
Feb 06, 2024	charge enterprises, inc.	19.3%	41,525,443	SC 13G/A
Jan 26, 2024	gabriel 613 trust	14.5%	31,093,906	SC 13G
Jan 12, 2024	arena investors lp	9.99%	21,580,180	SC 13D/A
Sep 11, 2023	arena investors lp	9.99%	21,574,039	SC 13D/A
Aug 21, 2023	arena investors lp	9.99%	21,574,039	SC 13D
Mar 20, 2023	arena investors lp	9.99%	20,676,104	SC 13G
Feb 07, 2023	charge enterprises, inc.	18.8%	38,912,943	SC 13G

Recent SEC filings of Clenergen Corp.

View All Filings

Date Filed	Form Type	Document
Apr 09, 2024	25-NSE	25-NSE
Mar 15, 2024	NT 10-K	NT 10-K
Mar 12, 2024	8-K	Current Report
Feb 28, 2024	8-K	Current Report
Feb 22, 2024	8-K	Current Report
Feb 16, 2024	SC 13D	13D - Major Acquisition
Feb 13, 2024	8-K	Current Report
Feb 12, 2024	8-K	Current Report
Feb 06, 2024	SC 13G/A	Major Ownership Report
Jan 26, 2024	SC 13G	Major Ownership Report

Clenergen Corp. News

Latest updates

Clenergen Corp. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In null)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Revenue	-10.4%	132,277	147,586	193,549	167,957	185,857	181,041	162,978	119,312	116,998	129,577	111,128	-
Gross Profit	16.4%	9,022	7,748	6,721	8,211	6,906	6,274	6,166	3,864	3,904	2,151	1,618	-
Operating Expenses	-5.2%	15,383	16,227	16,341	14,926	16,880	16,202	15,632	7,491	12,671	13,846	6,992	-
S&GA Expenses	-20.6%	4,315	5,433	3,345	2,827	3,516	6,452	2,742	2,649	1,928	2,141	1,299	-
EBITDA Margin	577.7%	0.02*	0.00*	0.00*	-	-	-	-	-	-	-	-	-
Interest Expenses	0.1%	1,489	1,488	1,538	5,866	1,015	7,160	1,765	3,685	486	268	181	-
Income Taxes	206.2%	741	242	-110	786	-8.00	45.00	1,373	-471	2,715	2,010	-1,182	-
Earnings Before Taxes	27.8%	-6,210	-8,604	-9,102	-	16,173	-17,115	-11,399	-	-	-	-	-
EBT Margin	55.0%	-0.01*	-0.03*	-0.03*	-	-	-	-	-	-	-	-	-
Net Income	21.4%	-6,951	-8,846	-9,212	-11,941	14,407	-19,642	-13,141	-14,781	-25,234	-10,147	-1,599	-
Net Income Margin	-156.8%	-0.06*	-0.02*	-0.04*	-0.04*	-0.05*	-0.13*	-0.12*	-0.11*	-0.09*	-0.12*	-0.19*	-0.41*
Free Cashflow	-Infinity%	-1,539	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet									(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2020Q4
Assets	-4.3%	188	196	183	168	188	207	187	142	99.00
Current Assets	-14.0%	126	147	133	117	130	150	128	108	80.00
Cash Equivalents	2.4%	51.00	50.00	36.00	27.00	36.00	47.00	26.00	18.00	12.00
Inventory	168.6%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Net PPE	-12.3%	0.00	1.00	1.00	1.00	2.00	2.00	2.00	2.00	2.00
Goodwill	104.4%	26.00	13.00	13.00	13.00	36.00	36.00	45.00	26.00	17.00
Liabilities	-5.0%	144	152	135	128	142	183	138	121	79.00
Current Liabilities	-9.1%	135	148	131	124	117	158	106	89.00	77.00
LT Debt, Current	3.8%	27.00	26.00	-	29.00	-	-	-	5.00	-
LT Debt, Non Current	-	-	-	-	-	-	-	-	31.00	-
Shareholder's Equity	-13.1%	24.00	28.00	32.00	24.00	28.00	6.00	40.00	14.00	21.00
Retained Earnings	-5.9%	-184	-174	-165	-155	-161	-175	-128	-103	-0.20
Additional Paid-In Capital	3.3%	209	202	197	180	191	20.00	20.00	118	0.00
Shares Outstanding	1.0%	215	213	207	207	206	191	188	184	140

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)												(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Cashflow From Operations	-108.4%	-1,498	17,811	10,916	-8,453	-18,553	920	14,716	-6,410	2,222	1,531	-249	-
Share Based Compensation	-	-	-	5,902	5,985	428	12,662	7,424	450	7,532	9,256	4,563	-
Cashflow From Investing	194.1%	3,391	-3,602	377	-2,496	9,876	5,855	-15,247	-5,040	-3,320	-16,340	-266	-
Cashflow From Financing	0.2%	-482	-483	-1,565	2,607	-1,810	13,537	8,659	20,332	359	14,228	-	-
Dividend Payments	0%	362	362	362	359	320	237	261	-	-	-	-	-

CRGE Income Statement

2023-09-30

Consolidated Statement of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues	$ 132,277	$ 185,857	$ 473,412	$ 529,876
Cost of sales	123,255		450,353
Gross profit	9,022		23,059
Operating expenses
General and administrative	4,315		14,854
Salaries and related benefits	8,890		27,173
Professional fees	1,006		1,918
Depreciation and amortization expense	1,172	433	3,574	1,745
Total operating expenses	15,383		47,519
(Loss) from operations	(6,361)		(24,460)
Other income (expenses):
Income (loss) from investments, net	675		1,637	(1,343)
Change in fair value of derivative liabilities	57		1,713	28,669
Interest expense	(1,489)		(4,515)
Loss on impairment	(56)		(114)	0
Other income (expense), net	848		1,876
Foreign exchange gain (loss)	116		(53)
Total other income (expenses), net	151		544
Income (loss) before income taxes	(6,210)	16,173	(23,916)	(12,341)
Income tax (expense) benefit	(741)	8	(1,093)	1,336
Net income (loss)	(6,951)	14,407	(25,009)	(11,005)
Less: Deemed dividend	(2,885)		(2,885)
Less: Preferred dividends	(362)		(1,086)
Net income (loss) available to common stockholders	$ (10,198)		$ (28,980)
Basic income (loss) per share available to common stockholders (in dollars per share)	$ (0.05)		$ (0.14)
Diluted income (loss) per share available to common stockholders (in dollars per share)	$ (0.05)		$ (0.14)
Weighted average number of shares outstanding, basic (in shares)	214,273		211,423
Weighted average number of shares outstanding, diluted (in shares)	214,273		211,423
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Revenues		185,857		529,876
Cost of sales		179,760		512,143
Gross profit		6,097		17,733
Operating expenses
General and administrative		5,141		17,200
Salaries and related benefits		7,850		23,597
Professional fees		666		2,578
Depreciation and amortization expense		433		1,745
Total operating expenses		14,090		45,120
(Loss) from operations		(7,993)		(27,387)
Other income (expenses):
Income (loss) from investments, net		(200)		(1,343)
Change in fair value of derivative liabilities		28,669		28,669
Interest expense		(1,015)		(9,939)
Loss on impairment		0		0
Other income (expense), net		(3,289)		(2,255)
Foreign exchange gain (loss)		1		(86)
Total other income (expenses), net		24,166		15,046
Income (loss) before income taxes		16,173		(12,341)
Income tax (expense) benefit		8		1,336
Net income (loss)		16,181		(11,005)
Less: Deemed dividend		0		(36,697)
Less: Preferred dividends		(302)		(922)
Net income (loss) available to common stockholders		$ 15,879		$ (48,624)
Basic income (loss) per share available to common stockholders (in dollars per share)		$ 0.07		$ (0.25)
Diluted income (loss) per share available to common stockholders (in dollars per share)		$ 0.06		$ (0.25)
Weighted average number of shares outstanding, basic (in shares)		206,225		196,126
Weighted average number of shares outstanding, diluted (in shares)		231,388		196,126

CRGE Balance Sheet

2023-09-30

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 51,359	$ 26,837
Restricted cash	886	886
Accounts receivable net of allowances of $68 in 2023 and $322 in 2022	55,768	72,405
Inventory	317	111
Deposits, prepaids and other current assets	3,430	3,187
Investments in marketable securities	5,868	6,757
Investments in non-marketable securities	279	236
Contract assets	8,128	6,090
Total current assets	126,035	116,509
Property, plant and equipment, net	485	732
Finance lease right-of-use assets	888	341
Operating lease right-of-use assets	3,123	4,028
Non-current assets	248	240
Goodwill	25,906	12,672
Intangible assets, net	30,832	33,932
Total Assets	187,517	168,454
Current liabilities
Accounts payable	73,105	61,644
Accrued liabilities	7,922	11,121
Contract liabilities	25,201	13,741
Derivative liability	2	6,521
Finance lease liabilities	242	112
Operating lease liabilities	1,183	1,579
Current portion of long-term debt	27,126	29,180
Total current liabilities	134,781	123,898
Non-current liabilities
Finance lease liabilities, non-current	530	146
Operating lease liabilities, non-current	1,808	2,199
Contingent consideration liability	5,758	0
Net deferred tax liability	1,072	1,410
Total Liabilities	143,949	127,653
Series C preferred stock (6,226,370 shares issued and outstanding at September 30, 2023, and December 31, 2022)	19,458	16,572
Commitments, contingencies and concentration risk
Stockholders' Equity
Common stock, $0.0001 par value; 750,000,000 shares authorized, 215,039,868 and 206,844,580 issued and outstanding at September 30, 2023 and December 31, 2022, respectively	21	20
Additional paid in capital	208,564	179,723
Accumulated deficit	(184,475)	(155,514)
Total Stockholders' Equity	24,110	24,229
Total Liabilities and Stockholders' Equity	187,517	168,454
Series C Preferred Stock [Member]
Non-current liabilities
Series C preferred stock (6,226,370 shares issued and outstanding at September 30, 2023, and December 31, 2022)	19,458	16,572
Series D Preferred Stock [Member]
Stockholders' Equity
Preferred stock	0	0
Series E Preferred Stock [Member]
Stockholders' Equity
Preferred stock	$ 0	$ 0

About Clenergen Corp.

Charge Enterprises Inc. operates as an electrical, broadband, and electric vehicle (EV) charging infrastructure company. The company provides clients with end-to-end project management services, including advising, designing, engineering, acquiring and installing equipment, monitoring, servicing, and maintenance. It operates in two segments, Infrastructure and Telecommunications. The Infrastructure segment offers broadband and wireless, electrical contracting, electric vehicle charging, and fleet services. The Telecommunications segment provides internet-protocol-based and time-division multiplexing access for transport of long-distance voice and data minutes; domestic switching and related peripheral equipment services, and carrier-grade routers and switches for internet and circuit-based services, as well as connection of voice calls and data services. The company was formerly known as TransWorld Holdings Inc and changed its name to Charge Enterprises, Inc. in January 2021. Charge Enterprises, Inc. was incorporated in 2003 and is based in New York, New York.

CEO	Mr. Craig Denson
WEBSITE	charge.us
INDUSTRY	Telecom Services
EMPLOYEES	332

Clenergen Corp. Frequently Asked Questions

What is the ticker symbol for Clenergen Corp.? What does CRGE stand for in stocks?

CRGE is the stock ticker symbol of Clenergen Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clenergen Corp. (CRGE)?

As of Tue Apr 23 2024, market cap of Clenergen Corp. is 2.15 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CRGE stock?

You can check CRGE's fair value in chart for subscribers.

What is the fair value of CRGE stock?

You can check CRGE's fair value in chart for subscribers. The fair value of Clenergen Corp. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clenergen Corp. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CRGE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clenergen Corp. a good stock to buy?

The fair value guage provides a quick view whether CRGE is over valued or under valued. Whether Clenergen Corp. is cheap or expensive depends on the assumptions which impact Clenergen Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CRGE.

What is Clenergen Corp.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, CRGE's PE ratio (Price to Earnings) is -0.06 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CRGE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Clenergen Corp.'s stock?

In the past 10 years, Clenergen Corp. has provided -0.324 (multiply by 100 for percentage) rate of return.